Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtronic...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021....
Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as...
Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice President and President, Cardiovascular...
The board of directors of Medtronic plc (NYSE: MDT) on Friday, December 11, 2020, approved the fiscal year 2021 third quarter cash dividend of $0.58 per ordinary share. This quarterly declaration...